LEGN
Legend Biotech (LEGN)
$65
About Legend Biotech (LEGN)
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Details
Daily high
$22.27
Daily low
$21.51
Price at open
$21.95
52 Week High
$45.30
52 Week Low
$21.51
Market cap
4.1B
Dividend yield
0.00%
Volume
2.3M
Avg. volume
2.7M
P/E ratio
-16.85
Legend Biotech News
Details
Daily high
$22.27
Daily low
$21.51
Price at open
$21.95
52 Week High
$45.30
52 Week Low
$21.51
Market cap
4.1B
Dividend yield
0.00%
Volume
2.3M
Avg. volume
2.7M
P/E ratio
-16.85